H X Chen

Information Fusion of Discrete Variables and Continuous Variables Based on D-S Evidential Theory

H H Yang, H H Sun, H X Chen, 2021 .

A population‐based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling

H X Chen, M. -. Chen, L. Xiong, 2004, Alimentary pharmacology & therapeutics.

Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab.

H X Chen, B. Cheson, R. Gore-Langton, 2001, Oncology.

Bevacizumab (BV) plus 5-FU/leucovorin (FU/LV) for advanced colorectal cancer (CRC) that progressed after standard chemotherapies: An NCI Treatment Referral Center trial (TRC-0301).

H X Chen, L. Grochow, M. Mooney, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collagen triple helix repeat containing‐1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma

H X Chen, Y. Tu, L. Wang, 2011, The British journal of dermatology.

Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma

H X Chen, P. LoRusso, R. Kurzrock, 2013, British Journal of Cancer.

Cixutumumab combined with temsirolimus in patients with refractory Ewing's sarcoma.

H X Chen, P. LoRusso, R. Kurzrock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of bevacizumab (B) with fluorouracil (F) and hydroxyurea (H) with concomitant radiotherapy (X) (B-FHX) for poor prognosis head and neck cancer (HNC).

H X Chen, R. Weichselbaum, E. Vokes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC).

H X Chen, G. Abou-Alfa, L. Saltz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bowel perforation and fistula formation in colorectal cancer patients treated on Eastern Cooperative Oncology Group (ECOG) studies E2200 and E3200.

H X Chen, P. Catalano, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.